Thomas, C.; Baunacke, M.; Erb, H.H.H.; Füssel, S.; Erdmann, K.; Putz, J.; Borkowetz, A.
Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored? Cancers 2022, 14, 8.
https://doi.org/10.3390/cancers14010008
AMA Style
Thomas C, Baunacke M, Erb HHH, Füssel S, Erdmann K, Putz J, Borkowetz A.
Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored? Cancers. 2022; 14(1):8.
https://doi.org/10.3390/cancers14010008
Chicago/Turabian Style
Thomas, Christian, Martin Baunacke, Holger H. H. Erb, Susanne Füssel, Kati Erdmann, Juliane Putz, and Angelika Borkowetz.
2022. "Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?" Cancers 14, no. 1: 8.
https://doi.org/10.3390/cancers14010008
APA Style
Thomas, C., Baunacke, M., Erb, H. H. H., Füssel, S., Erdmann, K., Putz, J., & Borkowetz, A.
(2022). Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored? Cancers, 14(1), 8.
https://doi.org/10.3390/cancers14010008
